Content deleted Content added
Entranced98 (talk | contribs) +sd |
m +WL Duobrii (w/ piping to Halobetasol/tazarotene) |
||
Line 57:
'''Ulobetasol''' ([[International Nonproprietary Name|INN]]) or '''halobetasol''' ([[United States Adopted Name|USAN]]) is a [[corticosteroid]] used to treat [[psoriasis]].<ref name="monograph">{{cite web|url=https://pdf.hres.ca/dpd_pm/00053569.PDF|title=Ultravate product monograph|access-date=2021-01-04}}</ref><ref>{{DrugBank|DB00596}}. Retrieved 2020-01-04.</ref> It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.<ref>{{cite journal | vauthors = Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB, Feldman SR | title = Class I topical corticosteroid use by psoriasis patients in an academic practice | journal = The Journal of Dermatological Treatment | volume = 15 | issue = 4 | pages = 235–8 | date = July 2004 | pmid = 15764038 | doi = 10.1080/09546630410033745 | s2cid = 2757493 }}</ref><ref>ATC code {{ATC|D07|AC21}}. Retrieved 2020-01-04.</ref>
[[Ulobetasol propionate]] is usually supplied as a 0.05% topical cream.<ref name="monograph" /> Ulobetasol is the strongest topical steroid available.{{cn|date=February 2017}} It is also sold with [[tazarotene]] with 0.01% halobetasol and 0.045% [[tazarotene]] as a lotion branded as [[halobetasol/tazarotene|Duobrii]] (Bausch Health).
It is available as a [[generic medication]].<ref>{{cite web | title=Ulobetasol international | website=Drugs.com | date=10 August 2020 | url=https://www.drugs.com/international/ulobetasol.html | access-date=15 August 2020}}</ref>
| |||